Angiotensin II regulation of the Na+ pump involves the phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways in vascular smooth muscle cells.
第一作者:
Esma R,Isenovic
第一单位:
Department of Cell Biology, State University of New York-Health Science Center, Brooklyn, 11201, USA.
作者:
主题词
阿米洛利(Amiloride);血管紧张素Ⅱ(Angiotensin II);动物(Animals);抗高血压药(Antihypertensive Agents);主动脉, 胸(Aorta, Thoracic);生物转运(Biological Transport);细胞, 培养的(Cells, Cultured);利尿药(Diuretics);洛沙坦(Losartan);MAP激酶信号系统(MAP Kinase Signaling System);丝裂原活化蛋白激酶1(Mitogen-Activated Protein Kinase 1);丝裂原活化蛋白激酶3(Mitogen-Activated Protein Kinase 3);丝裂原激活蛋白激酶类(Mitogen-Activated Protein Kinases);肌, 平滑, 血管(Muscle, Smooth, Vascular);磷酸肌醇3-激酶类(Phosphatidylinositol 3-Kinases);大鼠(Rats);大鼠, Sprague-Dawley(Rats, Sprague-Dawley);受体, 血管紧张素, 1型(Receptor, Angiotensin, Type 1);钠钾交换ATP酶(Sodium-Potassium-Exchanging ATPase);转录, 遗传(Transcription, Genetic);血管收缩药(Vasoconstrictor Agents)
DOI
10.1210/en.2003-0100
PMID
14630723
发布时间
2019-12-10
- 浏览10

Endocrinology
1151-60页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文